Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Constantin A. Dasanu, Juliana Alvarez-Argote & Catherine B Goff. (2022) Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. Expert Opinion on Pharmacotherapy 23:11, pages 1239-1241.
Read now
Read now
Kalman Filanovsky, Rinat Yacobi, Eliakim Vorst, Iris Barshack, Eva Ustaev, Edit Feldberg & Lev Shvidel. (2015) Second hematologic malignancies in hairy cell leukemia: report of two patients with dynamic mutations in the BRAF gene. Leukemia & Lymphoma 56:3, pages 823-825.
Read now
Read now
Constantin A. Dasanu, Magali Van den Bergh, Donna Pepito & Juliana Alvarez Argote. (2015) Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought?. Current Medical Research and Opinion 31:1, pages 17-23.
Read now
Read now
Eric Kraut. (2011) Infectious complications in hairy cell leukemia. Leukemia & Lymphoma 52:sup2, pages 50-52.
Read now
Read now
Tamar Tadmor. (2011) Purine analog toxicity in patients with hairy cell leukemia. Leukemia & Lymphoma 52:sup2, pages 38-42.
Read now
Read now
Articles from other publishers (11)
Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi & Lior Rokach. (2023) The course of patients with hairy cell leukemia during the omicron surge of the Covid‐19 pandemic. Hematological Oncology 41:5, pages 894-903.
Crossref
Crossref
Elsa Maitre, Jerome Paillassa & Xavier Troussard. (2022) Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. Frontiers in Oncology 12.
Crossref
Crossref
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, Ozren Jaksic, Milena Kohn, Francesco Marchesi, Monia Marchetti, Shaimaa El-Ashwah, Fatih Demirkan, Toni Valković, Noemí Fernández, Maria Chiara Tisi, Zlate Stojanoski, Guldane Cengiz Seval, Osman Ilhan, Lucia Prezioso, Maria Merelli, Alberto López-García, Marie-Pierre Ledoux, Austin Kulasekararaj, Tomás-José González-López, Maria Gomes da Silva, Ziad Emarah, Rafael F. Duarte, Chiara Cattaneo, Ola Blennow, Yavuz M. Bilgin, Rui Bergantim, Josip Batinić, Raul Cordoba, Jenna Essame, Anna Nordlander, Raquel Nunes Rodrigues, Maria Vittoria Sacchi, Sofia Zompi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Rémy Duléry, Oliver A. Cornely, Caroline Besson & Livio Pagano. (2022) COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. Blood Advances 6:13, pages 3870-3874.
Crossref
Crossref
L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian & G.M. Galstyan. (2022) Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia. Clinical oncohematology 15:4, pages 349-355.
Crossref
Crossref
Svetlana Yu. Smirnova, Lyubov S. Al-Radi, Tatyana N. Moiseeva, Eduard G. Gemdzhian, Igor A. Yakutik, Hunan L. Julhakyan, Vyacheslav A. Novikov, Gennady M. Galstyan & Andrey B. Sudarikov. (2021) Inhibitor of BRAFV600E Mutation as a Treatment Option for Hairy Cell Leukemia With Deep Neutropenia and Infectious Complications. Clinical Lymphoma Myeloma and Leukemia 21:7, pages 427-430.
Crossref
Crossref
M Mateo-Casas, S Reyes, EA O'Toole, S De Trane, O Yildiz, K Allen-Philbey, J Mathews, D Baker, G Giovannoni & K Schmierer. (2020) Severe skin reactions associated with cladribine in people with multiple sclerosis. Multiple Sclerosis and Related Disorders 43, pages 102140.
Crossref
Crossref
Alexander Pemov, Anand Pathak, Samantha J. Jones, Ramita Dewan, Jessica Merberg, Sirisha Karra, Jung Kim, Evgeny Arons, Sarangan Ravichandran, Brian T. Luke, Shalabh Suman, Meredith Yeager, Martin J. S. Dyer, Henry T. Lynch, Mark H. Greene, Neil E. Caporaso, Robert J. Kreitman, Lynn R. Goldin, John J. Spinelli, Angela Brooks-Wilson, Mary L. McMaster & Douglas R. Stewart. (2020) In search of genetic factors predisposing to familial hairy cell leukemia (HCL): exome-sequencing of four multiplex HCL pedigrees. Leukemia 34:7, pages 1934-1938.
Crossref
Crossref
Tamar Tadmor, Ilana Levy, Yair Herishanu, Neta Goldschmidt, Osnat Bairey, Mona Yuklea, Lev Shvidel, Riva Fineman, Ariel Aviv, Rosa Ruchlemer, Andrei Braester, Dally Najib, Ory Rouvio, Adir Shaulov, Uri Greenbaum, Michal Inbar & Aaron Polliack. (2019) Primary peg-filgrastim prophylaxis versus filgrastim given “on demand” for neutropenia during therapy with cladribine for hairy cell leukemia. Leukemia Research.
Crossref
Crossref
Robert P. Hasserjian. 2018. Diagnosis of Blood and Bone Marrow Disorders. Diagnosis of Blood and Bone Marrow Disorders
329
381
.
Frank J Senatore & Constantin A Dasanu. (2015) Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior. Journal of Oncology Pharmacy Practice 22:3, pages 543-547.
Crossref
Crossref
Taichi Ikebe, Hitohiro Sasaki, Hiroyuki Takata, Yasuhiko Miyazaki, Eiichi Ohtsuka, Yoshio Saburi, Masao Ogata & Kuniaki Shirao. (2016) Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant. Internal Medicine 55:21, pages 3175-3180.
Crossref
Crossref